The last 20 actions on file set price targets from $263.00 to $315.00, averaging $286.26.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 28 Sep 2026 | Raymond James | BUY | $285.00 |
| 22 Sep 2026 | BMO Capital | HOLD | $265.00 |
| 17 Sep 2026 | Leerink Partners | BUY | – |
| 14 Sep 2026 | Morgan Stanley | BUY | $274.00 |
| 1 Sep 2026 | J.P. Morgan | BUY | $315.00 |
| 25 Aug 2026 | UBS | BUY | $308.00 |
| 10 Aug 2026 | Mizuho Securities | BUY | $290.00 |
| 10 Aug 2026 | BofA Securities | BUY | $295.00 |
| 31 Jul 2026 | Wells Fargo | BUY | $281.00 |
| 29 Jul 2026 | Goldman Sachs | BUY | $305.00 |
| 28 Jul 2026 | Truist Financial | BUY | $290.00 |
| 28 Jul 2026 | Baird | HOLD | $280.00 |
| 28 Jul 2026 | Goldman Sachs | BUY | $305.00 |
| 27 Jul 2026 | TD Cowen | BUY | $263.00 |
| 27 Jul 2026 | UBS | BUY | $308.00 |
| 27 Jul 2026 | Truist Financial | BUY | $270.00 |
| 27 Jul 2026 | Morgan Stanley | BUY | $274.00 |
| 27 Jul 2026 | Stephens | BUY | $285.00 |
| 27 Jul 2026 | Guggenheim | BUY | $283.00 |
| 26 Jul 2026 | TD Cowen | BUY | $263.00 |
No comments yet — be the first to weigh in on THC.